R2032281 |
TAK-285 |
TAK-285 is a potent, selective, ATP-competitive and orally active HER2 and EGFR(
|
R2032282 |
SC1(Pluripotin) |
Pluripotin is a dual inhibitor of ERK1 and RasGAP with KDs of 98 nM and 212 nM,
|
R2032283 |
AZD8186 |
AZD8186 is a PI3K inhibitor, which potently inhibits PI3Kβ (IC50=4 nM) and PI3Kδ
|
R2032284 |
SRT3109 |
SRT3109 is an antagonist of CXCR2, with a pIC50 of 8.2, and used in the research
|
R2032285 |
TG101209 |
TG101209 is a selective JAK2 inhibitor with IC50 of 6 nM, less potent to Flt3 an
|
R2032286 |
CC-223 |
CC-223 is a potent, selective, and orally bioavailable inhibitor of mTOR kinase,
|
R2032287 |
Bexagliflozin;EGT1442;EGT0001442;THR-1442 |
Bexagliflozin is a potent and selective SGLT2 inhibitor with IC50 value of 5.6 μ
|
R2032288 |
MK-886 (L 663536) |
MK-886 (L 663536) is a potent, cell-permeable and orally active FLAP (IC50 of 30
|
R2032289 |
ABT639;ABT-639 |
ABT-639 is a novel, peripherally acting, selective T-type Ca2+ channel blocker.
|
R2032290 |
CHIR-090;CHIR090 |
CHIR-090 is a potent, slow, tight-binding inhibitor of the LpxC deacetylase.It b
|
R2032291 |
FLT3-IN-2 |
FLT3-IN-2 is a FLT3 inhibitor with IC50 of < 1 μM, detailed information refer to
|
R2032292 |
GDC0084 |
GDC-0084 is a brain penetrant inhibitor of PI3K and mTOR, with Kis of 2 nM, 46 n
|
R2032293 |
AC710 |
AC710 is a potent PDGFR inhibitor with Kds of 0.6, 1.57, 1, 1.3, 1.0 nM for FLT3
|
R2032294 |
P7C3-A20 |
P7C3-A20 is a derivative of P7C3 with potent neuroprotective activity.
|
R2032295 |
NSC23766;NSC-23766 |
NSC 23766 is a specific inhibitor of the binding and activation of Rac GTPase, u
|
R2032296 |
GSK484 hydrochloride(GTPL8577) |
GSK484 hydrochloride (GTPL8577) is a selective and reversible peptidylarginine d
|
R2032297 |
GDC-0810;Lifirafenib(BGB-283) |
Lifirafenib (BGB-283) is a novel and potent Raf Kinase and EGFR inhibitor with I
|
R2032298 |
A 769662 |
A-769662 is a potent, reversible AMPK activator with EC50 of 0.8 μM.
|
R2032299 |
MT-1303;Amiselimod |
Amiselimod is a novel sphingosine 1-phosphate receptor-1 (S1P1) modulator, desig
|
R2032301 |
SB415286 |
SB 415286 is a potent and selective cell permeable inhibitor of GSK-3α, with an
|
R2032302 |
Tomivosertib(eFT508) |
Tomivosertib (eFT508) is a potent, highly selective, and orally bioavailable MNK
|
R2032303 |
AG-1478;Tyrphostin AG-1478;NSC 693255 |
AG-1478 is a selective EGFR tyrosine kinase inhibitor with IC50 of 3 nM.
|
R2032304 |
KPT9274 |
KPT-9274 is an orally bioavailable, dual PAK4/Nicotinamide phosphoribosyltransfe
|
R2032305 |
Lanabecestat;AZD3293;LY3314814 |
Lanabecestat (AZD3293) is a potent, highly permeable, orally active and blood-br
|
R2032306 |
RX-518 |
EGFR-IN-3 is an epidermal growth factor receptor (EGFR) inhibitor.
|